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Gastroscopy is the main method for diagnosing malignant disease of the stomach.  
The aim of the paper was to prove that endoscopic results together with intraoperative 
finding  determine the type and extensiveness of the cancer operation.  
The study included 70 patients, all of them with the diagnosis of cancer or 
adenocarcenoma of the stomach, using the method of gastroscopy and pathohistological 
(PH) verification. Of this number, 38 patients underwent radical operation (total or 
subtotal gastrectomy) with systemic lymphadenectonomy; 15 patients underwent 
palliative operation for improving the quality of life; 15 patients underwent explorative 
laparatomy for making the final diagnosis and possible palliative operation; 2 patients died 
due to poor general medical condition of the organism after making the endoscopic and 
pathohistological diagnosis. The obtained data were processed and presented in tables and 
charts. In all applied analytical methods, the level of significance was 0,05.  
The treatment outcome did not depend on the localization (regio antri et pylori, regio 
cardiae, regio pangastrica, regio corporisi) and macroscopic finding of the tumor 
(ulceroinfiltrative, diffuse infiltrative, ulcerative, fungoid form). Worse TNM status, worse P 
and H classification in the patients before the applied therapy significantly influenced the 
survival rate. Similar findings were also comfirmed for the definitive TNM status, P and H 
classification. The treatment outcome was significantly influenced by the pH finding, as 
intestinal type of cancer prevailed in the deceased. Prognostically, the presence of 
metastases  had the worst influence on the course and outcome of the treatment.   
Early diagnosis of stomach cancer is of greatest importance for survival of these 
patients. Tumor size (T), the pathohistological result (PH) and lymphonodal status (N) 
significantly influence the extent of radical operative treatment  and distant metastases. 
By applying radical lymphadenectomy with total and subtotal gastrescomy, survival length 
increases, which we expect in our patients whose health is constantly being monitored; 
they are in a good general medical condition, with no signs of relapse. By applying radical 
extensive lymphadenectomy, the rate of survival is increased. Acta Medica Medianae 
2008;47(3):44-50. 
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Introduction 
 
Treatment of stomach malign illnesses 
(cancers)  
 
So far, surgical treatment has been the 
only known way for treating stomach cancer 
successfully (1,2,3,4). 
As far as surgical therapy in stomach 
cancer treatmentis is concerned, differentiation 
between terms resectability and operability 
should be made.  
The term resectability implies that the 
technical act is justified only if there are no 
distant metastases.  
Operability, as a term, refers to a biological 
development of a malign tumor.  
It means that a tumor with distant 
metastases is biologically inoperable but it can be 
technically resectable. In other words, a tumor 
can be operable because there are no distant 
metastases but its resectability can be at stake in 
cases where tumor has spread on the adjacent 
organs and blood vessels.  
Clinical signs of inoperability are: 
supraclavicular adenopathy, clearly palpable 
tumor mass, signs of ascites  and palpable liver 
nodes.  
Intraoperative signs of inoperability are: 
tumorous infiltration of adjacent organs and 
blood vessels, distant metastases (in liver), 
carcinoma of peritoneum and ascites. Metastases Acta Medica Medianae 2008,Vol.47                                        The effect of endoscopic and intraoperative results on the type and... 
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in regional lymph nodes do not necessarily mean 
inoperability because radical operation always 
includes systemic lymphadenectomy.  
Contemporary operative technique is based 
on two principles (5,6): 
•  removal of lesion where the borders of 
resection must be within healthy tissue 
(resection in healthy tissue) and  
•  removal of all regional lymph nodes 
(systemic lymphadenectomy).  
In intestinal type of carcinoma, resection 
borders must be in oral direction at least 5 cm 
set away from a microscopically visible tumor 
borders. In diffuse type of carcinoma, resection 
border is set orally 10 cm from the visible tumor 
border. Radical surgical treatment includes total and 
subtotal gastrectomy with D2 lymphadenectomy 
(7,8). 
Radical surgery implies the removal of 
omentum, total gastrectomy, splenectomy and 
systemic lymphadenectomy (suprapilorus, infrapilo-
rus, epiploic, celiac, cardial, retropancreatic and a 
group of nodes around liver hilus). Reconstruction 
is done according to ‘’omega’’ type, which means 
termino-lateral ezofagojejuno anastomosis with 
obligatory jejunojejuno anastomosis. However, 
nowadays, doctors mostly do reconstruction with 
isolated jejunal circumvolution (Roux) using a 
mechanical joint (stapler) (9,10,11). 
Subtotal resection has indications only in 
older persons or in cases of superficial carcinoma 
(early cancer) localized in the prepiluros region 
with no signs of metastatic changes in celial and 
cardial group of lymph nodes, verified ex 
tempore during the operation (8,9,10). 
Gastroenteroanastomosis, as one of the 
types of palliative surgery, enables stomach 
functions.  
Therapy of metastases in the liver in terms 
of resection is logical in cases when a metastatic 
change is solitary or if the target of a change is 
only in one lobus. Good results can be achieved 
also by embolisation using cateterisation and 
injecting cytostatics 5-Fluorouracila or a 
combination of three cytostatics. (5-Fluorouracil, 
Adriacin i Mitomicin C), as well as injecting 
nitrosourea preparations. Monocytostatic therapy 
has approximately 20% of partial remissions and 
using, for example, FAM protocol (5-
Fluorouracil+Adriamycin +Mitomycin C) we can 
reach an answer of 40%. However, it is 
necessary to say that remissions which occur are 
of relatively short duration and that cytostatic 
therapy at stomach carcinoma does not give 
good results (9,10,12). 
 
Aims  
 
1.To prove that endoscopic results with 
intraoperative finding determine the type and 
extensiveness of an operation in case of carcinoma. 
 
Material and methods 
 
This study included 70 patients, all of them 
with the diagnosis of cancer or adenocarcenoma 
of the stomach, using the method of gastroscopy 
and a pathohistological (PH) verification. From 
this group, 38 patients underwent radical operation 
(total or subtotal gastrectomy) with a systemic 
lymphadenectonomy, 15 patients underwent 
palliative operation for improving the quality of 
life, 15 patients underwent explorative laparatomy 
for establishing the final diagnosis and eventual 
palliative operation, 2 patients  died due to poor 
general medical state of the organism after 
endoscopic and pathohistological diagnoses had 
been made.  
The data are retrosceptive-prospective, 
gathered in a MC Cacak in Cacak, for the period 
2003 – 2006.  
The data have held a diagnostic standard 
for a stomach carcinoma which includes: medical 
history, clinical examination, laboratory results 
(blood picture: HGB, HCT, MCV, Fe), radiography 
of the stomach, gastroscopy with the stomach 
biopsy and pathohistological verification (PH), 
digitorectal examination (cul de sac phenomenon), 
X-ray of heart, lungs and bone system. 
Apart from basic diagnostic procedures, the 
following ones were also performed: 
  Endosonography of the stomach 
  Ultrasound of the abdomen, if necessary 
a scanner (CT) of the abdomen with a contrast 
  Scintigraphy of the liver 
  Tumor markers (CA-50. CA-19-9)  
 Immunological  status 
 Laparoscopy   
 Explorative  laparatomy 
 
 Questionnaire for malignant illnesses 
Questionnaire was based on standard and non-
standard procedures during diagnosis of patients 
with gastric cancer (2,3,5,13). 
•  Name and surname  
•  Gender 
•  Age 
•  Address 
•  Gastroscopy 
•  Staging of disease (stage before the 
operation – used TNM classification) 
(stage after the operation)  
•  Histological type of tumor: 
o  Diffuse 
o  Intestinal 
o  Undetermined 
•  Macroscopic view of a tumor: 
o  Fungoid form 
o  Ulcerous form 
o  Ulcero-infiltrative form 
o  Diffuse-infiltrative form 
•  Lymphonodal  status  
•  Type of operation :   
o  Radical operation 
o  Palliative operation 
o  Explorative operation 
•  Type of  resection:  
o  Total gastrectomy 
o  Subtotal gastrectomy 
•  Outcome : 
o   Alive 
o  Passed away The effect of endoscopic and intraoperative results on the type and...                                    Aleksandra Ž Krstić 
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TNM classification (4,14) 
 
•  T1– invasion of a tumor into the mucosa or 
submucosa  T2 – invasion of a tumor in m. 
propria or subserosus layer, T3 – penetration 
of tumor into the serosa, T4 – invasion of 
tumor into the adjacent structures.  
•  N0- no evidence of metastases of lymph node; 
N1 - metastases up to a group 1 lymph nodes, 
but none up to groups 2, 3 and 4; N2 - 
metastases up to a group 2 lymph nodes, but 
none up to a lymph nodes 3 and 4; N3 - 
metastases up to a group 3 lymph nodes, but 
without metastases up to lymph nodes of 
group 4; N4 - metastases in lymph nodes of 
group 4. 
•  P0- no peritoneal metastases; P1 - 
metastases up to nearby peritoneum but not 
to a distant peritoneum; P2 – a few 
metastases up to a distant peritoneum; P3 - 
numerous metastases up to a distant 
peritoneum. Nearby peritoneum: Peritoneum 
of a smaller bag and a smaller and bigger 
omentum. 
•  H0– no sign of liver metastases; H1 - 
metastases limited to a single lobus, H1 (dex) 
-metastases limited to the right lobus, H1 
(sin) - metastases limited to the left lobus; 
H2 – a few metastases in both lobuses; H3 - 
numerous metastases in both lobuses.  
•  M0– no signs of distant metastases except 
peritoneal or liver metastases. 
•  M1- distant metastases except for peritoneal 
or liver metastases. 
Category  M1 should be specified under the 
following marks:  
Brain (BRA), Bone marrow (MAR), Meninges 
(MEN), Bone (OSS), Pleura (PLE), Pulmonary 
(PUL), Skin (SKI), Pleura (PLE), Other (OTH).  
 
Statistic methodology 
 
Received data are processed and shown in 
the tables and charts together with an appropriate 
discussion on the subject and all depending on 
nature of the stated variable.  
Descriptions of numerical marks in our 
study are made by classic methods of descriptive 
statistics using arithmetical average values, and 
also by median of average values, and of 
variability measures by standard deviation, 
coefficient of variation and standard error, as well 
as by using minimal and maximal values. 
Relative numbers are used in all tables.  
In our analyses, depending of the nature 
of variables, we used Pearson’s chi- square test, 
in the form of matching tests and contingency 
tables, for comparing differences between 
frequencies in non-parametric features. In 
numerical limitations of a table two by two, we 
used the Fischer’s test of exact probability.  
For comparison of the Student’s test for 
two groups of data. As a non-parametric addition 
to independent samples, we used a summary-
range test, and to dependant samples we used a 
test of equivalent pairs.  
In comparison of three or more groups of 
d a t a ,  w e  u s e d  F i s c h e r ’ s  p a r a m e t r i c  a n a l y s i s  o f  
variance (ANOVA) in parametric data, and non-
parametric analysis of variance for a proportion 
in non-parametric data.  
In an analysis of association, methods of 
single or multiple correlation and regression were 
used.  
For the analysis of survival predicting and 
for development of hypertension, we used Cox’s 
proportional hazardous method and logistic 
regression invariant in control with Log rank test 
for a comparisons between groups.  
All applied analytical methods have shown 
a level of significance 0.05.  
For creation of database and processing of 
data, a program named ‘’Institute’’, made by 
Department for medical statistics and computer 
science at the Faculty of Medicine,University of 
Belgrade was used. 
 
Results 
 
Table 1 shows the frequency of tumor 
localisation in regard to the treatment outcome.  
 
Table 1. Frequency of tumor localisation in regard to 
treatment outcome 
 
Tumor localizations   
regio 
antri et 
pylori 
regio 
cardiae 
regio 
pangast
rica 
regio 
corpori
s 
Total 
Alive   12 5 1 8  26  Outco
me  Passed 
away  18 6 9 11  44 
Total  30  11 10 19  70 
 
The analysis of tumor localisation frequency 
in regard to the treatment outcome showed that 
there was no statistically significant difference 
(F=3,786; df=3; p>0,05), which was the result 
of having all localizations relatively regurarly 
arranged in both outcomes.  
Table 2 shows the frequency of 
macroscopic tumor findings in regard to the 
treatment outcome.   
 
Table 2. Frequency of macroscopic tumor 
findings in regard to the treatment outcome 
  
Macroscopic finding 
  ulcero 
infiltrative 
diffuse-
infiltrativ
e 
ulcerativ
e 
fungoid
al form 
Total 
 
Alive   9 12  4  1  26  Outco
me  Passed 
away  22 16  3 3  44 
Total 31  28  7  4  70 
 
The analysis of frequency of macroscopic 
tumor findings regarding the treatment outcome 
showed that there was no statistically significant Acta Medica Medianae 2008,Vol.47                                        The effect of endoscopic and intraoperative results on the type and... 
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difference (F=2,717; df=3; p>0,05), which was the 
result of the fact that both outcomes were equally 
distributed.  
Table 3 shows the frequency of carcinoma 
metastases in regard to the treatment outcome.  
 
Table 3. Frequency of carcinoma metastases in regard to 
the treatment outcome 
 
Metastases 
  Developing   Not 
developing 
Total 
Alive  7  19 26 
Outcome  Passed 
away 
3  41 44 
Total 10  60  70 
 
The analysis of frequency of carcinoma 
metastases in regard to the treatment outcome 
showed that thre was high statistically significant 
difference  (χ2=5,395; df=1; p<0,01), which was 
the result of having a smaller number of metastases 
developing in the patients who survived than in 
the patients who passed away (ratio of 
metastases occurrence was 73.0 to 93.2%). 
Table 4 shows the frequency of T 
classification before the therapy in respect to the 
treatment outcome.  
 
Table 4. Frequency of T classification before the therapy 
in respect to the treatment outcome 
 
T before TH 
 
T1  T2 T3 T4 
Total 
 
Alive  2 4  16  4  26  Outco
me  Passed 
away  0 3  14  21  38 
Total 2 7  30  25  64 
 
The analysis of the frequency of T 
classification before the therapy shows that there 
was high  statistically significant difference 
(F=9,108; df=3; p<0,01), and this is the result 
of the fact that the patients with T3 stage were 
more frequent in the survived,whereas the 
passed away were mostly in T4 stage (ratio is 
61.5 to 55.3%). 
Table 5 shows the frequency of N 
classification before the therapy in respect to the 
treatment outcome.   
 
Table 5.  The frequency of N classification 
before the therapy in respect to the treatment 
outcome   
 
N before TH 
 
N0  N1  N2 N3 N4 
Total 
 
Alive   7  16  2 1 0  26 
Outco
me 
Passe
d 
away 
4 11 7  17 1  38 
Total  11 27  9 18  1 64 
 
The analysis of frequency of N classification 
in respect to the treatment outcome shows that 
there was high statistically significant difference 
(F=17, 565; df=3; p<0,01), which is the result of 
the survived mostly being in a N1 stage whereas 
the passed away mostly being in N2 and N3 
(ratio is 61.5 to 60.0%). 
Table 6 shows the frequency of P 
classification before the therapy in respect to the 
treatment outcome.    
 
Table 6. The frequency of P classification before the 
therapy in respect to the treatment outcome 
 
P before TH  Total 
 
T1 T2 T3  
Alive   26 0  0  26  Outco
me  Passed 
away 
25 1  14  40 
Total  51 1  14 66 
 
The analysis of the frequency of P 
classification before the therapy shows that there 
was high statistically significant difference 
(F=12,618; df=2; p<0,01), which was the result 
of the survived mostly being in  P0 stage whereas 
the passed away mostly being in P3 (ratio for P3 
is 0.0 to 35.0%).   
Table 7 shows the frequency of H 
classification before the therapy in respect to the 
treatment outcome.    
 
Table 7.  The frequency of H classification before the 
therapy in respect to the treatment outcome. 
 
H before TH  Total 
 
H0 H1  H3   
Alive   26 0  0  26  Outco
me  Passed 
away 
26 3  11  40 
Total 52  3  11  66 
 
The analysis of the frequency of H classification 
before the therapy in respect to the treatment 
outcome showed that there was high statistically 
significant difference (F=11,550; df=3; p<0,01), 
which was the result of the survived mostly being in 
a H0 stage, whereas the passed away mostly being 
in H3 (ratio for H3 is 0.0 to 27.5%). 
Table 8 shows the frequency of our patients 
regarding the outcome of the treatment and M 
classification before the therapy.  
 
Table 8. The frequency of our patients regarding the 
outcome of the treatment and M classification before the 
therapy 
 
M before TH  Total 
 
M0 M1  M2   
Alive   23 1  2  26  Outco
me  Passed 
away 
30 9  1  40 
Total 53  10  3  66 
 
The analysis of frequency of our patients 
regarding the outcome of the treatment and M The effect of endoscopic and intraoperative results on the type and...                                    Aleksandra Ž Krstić 
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classification before the therapy shows that there 
was no statistically significant difference 
(F=4,909; df=3; p>0,05), which was the result 
of having stages of M classification relatively 
equally distributed in both the survived and the 
deceased groups.  
Table 9 shows the frequency of pH tumor 
findings in respect to the treatment outcome.  
 
Table 9. The frequency of ph tumor findings in respect 
to the treatment outcome 
 
PH 
 
intestinal diffuse 
Total 
Alive   12 13  25  Outco
me  Passed 
away 
30 13  43 
Total  42 26 68 
 
The analysis of the frequency of the pH 
tumor finding in respect to the treatment outcome 
showed that there was high statistically significant 
difference (χ2=3,772; df=1; p<0,05), which was 
the result of the survived having evenly present 
both ph variants, whereas the intestinal type was 
dominant in the deceased (ratio for intestinal 70.0 
to 48.0%). 
Table 10 shows the frequency of definite T 
tumor classification in respect to the treatment 
outcome.  
 
Table 10. The frequency of definite T tumor classification 
in respect to the treatment outcome 
 
T before TH 
 
T1  T2 T3 T4 
Total 
 
Alive   24 1 1 0 26  Outco
me  Passed 
away  14 2 4 20  40 
Total  38 3 5 20  66 
 
The analysis of the frequency of T tumor 
classification in respect to the treatment outcome 
showed that there was high statistically significant 
difference (F=22,822; df=3; p<0,01), which was 
the result of the survived being mostly in T0 stage, 
whereas T4  prevailed in the deceased (ratio for T4 
is 0.0 to 50.0%). 
Table 11 shows the frequency of definite N 
tumor classification in respect to the treatment outcome  
 
Table 11. The frequency of definite N tumor classification 
in respect to the treatment outcome 
 
Definite N 
 
N0 N1  N2  N3 
Total 
 
Alive   23 3 0 0 26  Outco
me  Passed 
away  14 4 5 1 40 
Total  37 7 5 1  66 
 
The analysis of the frequency of definite N 
tumor classification in respect to the treatment 
outcome showed high statistically significant 
difference (F=22,369; df=4; p<0,01), which was 
the result of the survived being mostly in N0 
stage, whereas N3 was dominant in the deceased 
(ratio for N0 is 88.5 to 35.0%). 
Table 12 shows the frequency of definite P 
tumor classification in respect the treatment 
outcome.   
 
Table 12. The frequency of definite P tumor 
classification in respect the treatment outcome 
 
Definite P 
 
P0 P1  P3 
Total 
Alive   26 0  0  26  Outco
me  Passed 
away  25 2  13  40 
Total 51  2  13  66 
 
The analysis of the frequency of P tumor 
classification in respect to the treatment outcome 
showed that there was high statistically 
significant difference (F=12,618; df=2; p<0,01), 
which was the result of the survived being mostly 
in P0 stage, whereas P3 was dominant in the 
deceased (ratio for P0 is 100.0 to 65.0%). 
Table 13 shows the frequency of definite H 
tumor classification in respect the treatment 
outcome.   
 
Table 13. The frequency of definite H tumor 
classification in respect the treatment outcome 
 
Definite H 
 
H0 H1  H3 
Total 
Alive   26 0  0  26  Outco
me  Passed 
away  26 2  12  40 
Total 52  2  12  66 
 
The analysis of the definite H classification 
frequency in respect to the treatment outcome 
showed that there was high statistically 
significant difference (F=11,550; df=2; p<0,01), 
which was the result of the survived being mostly 
in H0 stage, whereas H3 was dominant in the 
deceased (ratio for H0 is 100.0 to 65.0%). 
Table 14 shows the frequency of definite M 
tumor classification in respect to the treatment 
outcome.   
 
Table 14. The frequency of definite M tumor 
classification in respect to the treatment outcome 
 
Definite M 
 
M0 M1  M2 
Total 
Alive   25 0  1  26  Outco
me  Passed 
away  32 6  2  40 
Total  57  6 3 66 
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The analysis of M tumor classification 
frequency before the therapy showed that there was 
no high statistically significant difference (F=4,442; 
df=2; p>0,05), which was the result of having the 
stages of M classification relatively evenly distributed 
in both the survived and the deceased, with the 
domination of M0.  
Table 15 shows the frequency of the operation 
type applied in the treatment of tumor in respect to 
the treatment outcome.   
 
Table 15. The frequency of the operation type applied in the 
treatment of tumor in respect to the treatment outcome. 
 
Operation 
  palliative explorative 
laparatomy 
radical  Total 
Alive   1 0  25  26  Outco
me  Passed 
away  14 15  13  42 
Total 15 15  38  68 
 
The analysis of the frequency of the 
operation type applied in the treatment of tumor in 
respect to the treatment outcome showed that 
there was high statistically significant difference 
(F=27, 832; df=2; p<0,01), which was the result of 
the fact that the survived mostly underwent radical 
surgeries and the deceased mostly underwent 
palliative operations and explorative laparatomy 
(ratio for radical surgeries is 96.2 to 30.9%). 
 
Discussion 
 
The analysis of the frequency of our 
patients regarding the outcome of the treatment 
and tumor localization as well as macroscopic 
results shows that there is no statistically 
significant difference, which is the result of the 
fact that all localizations and macroscopic results 
were relatively equally distributed.  
The analysis of frequency of our patients 
regarding the outcome of the treatment and 
metastatic findings shows that there was high 
statistically significant difference, which is the 
result of having a smaller number of metastases 
developing in the patients who survived than in 
those who passed away (ratio of metastases 
occurence was 73.0 to 93.2%).  
The analysis of frequency of our patients 
regarding the outcome of the treatment and the 
type of the operation of the tumor shows that 
there is high statistically significant difference, 
which is the result of the fact that the survived 
mostly underwent radical surgeries and the 
deceased mostly underwent palliative operations 
and explorative laparatomy (ratio for radical 
surgeries is 96.2 to 30.9%). 
The data presented here confirm that the 
best organized services (Japan) detect early 
stomach cancer in 30% of the cases, whereas 
European health services detect stomach cancer 
mostly in 10% of the cases, which means that 
the patients usually come with a malignant 
stomach carcinoma in an advanced stage. With 
earlier developmental stage of carcinoma 
(smaller extent of an infected stomach tissue, 
smaller percentage of the infected lymph nodes, 
no metastases) there is greater possibility for 
radical cure (2,3,4,5). On the contrary, there are 
some situations such as clinical signs of 
inoperability: supraclavicular adenopathy, clearly 
palpable tumor mass, signs of ascites and 
palpable liver nodes, as well as intraoperative 
signs of inoperability: tumorous infiltration of 
nearby organs and blood vessels, distant 
metastases - in liver, carcinoma of peritoneum 
and ascites) when it is possible to perform only 
palliative and explorative surgery (2,4,9,10,15). 
 
Conclusions 
 
Early diagnostics of stomach cancer has the 
greatest importance for the survival of these 
patients. 
Size of a tumor (T), pathohistological result 
(PH), and lymphonodal status (N) have great 
impact on the extent of radical operative 
treatment and distant metastases.  
By applying radical lymphadenectomy with 
a total and subtotal gastrectomy, the duration of 
survival increases. This is the case with our 
patients who are constantly monitored and are in  
good general medical condition with no signs of 
relapse.  
The use of radical extensive lymphadenectomy 
increases the rate of survival. 
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UTICAJ ENDOSKOPSKOG I INTRAOPERATIVNOG NALAZA NA VRSTU I 
OPSEŽNOST OPERACIJE KARCINOMA ŽELUCA 
 
Aleksandra Ž. Krstić 
 
 
Gastroskopija je glavna metoda za dijagnostiku malignih oboljenja želuca. 
Cilj rada bio je da se dokaže da endoskopski nalaz uz intraoperativni nalaz utvrđuje 
vrstu i opsežnost operacije kod karcinoma. 
U ovom radu je obrađivano 70 bolesnika, od kojih su svi imali dijagnostikovan karci-
nom ili adenokarcinom želuca, putem gastroskopije i sa patohistološkom (PH) verifika-
cijom. Od toga, 38 bolesnika je operisano radikalnom operacijom (totalnom ili subtotalnom 
gastrektomijom) sa sistemskom limfadenektomijom, kod 15 bolesnika je urađena palija-
tivna operacija radi poboljšanja kvaliteta života a kod 15 bolesnika je urađena eksplo-
rativna laparotomija radi postavljanja konačne dijagnoze i eventualne palijativne operacije, 
a dva bolesnika su umrla usled lošeg opšteg zdravstvenog stanja nakon postavljana 
endoskopske i patohistološke dijagnoze. U svim primenjenim analitičkim metodama nivo 
značajnosti bio je 0,05. 
Ishod lečenja nije zavisio od lokalizacije (regio antri et pylori, regio cardiae, regio 
pangastrica, regio corporisi) i makroskopskog nalaza (ulcero infiltrativni, difuzno infiltra-
tivni, ulcerativni, fungoidna forma) tumora. Lošiji TNM status, lošija P i H klasifikacija kod 
bolesnika pre primenjene terapije imaju značajan uticaj na stopu preživljavanja bolesnika. 
Slični nalazi su potvrđeni i za definitivni TNM status, P i H klasifikaciju. Ishod lečenja je 
značajno zavisio od ph nalaza tumora, jer je kod umrlih bolesnika preovladavao intestinalni 
tip karcinoma. Prisustvo metastaza imalo je prognostički najnepovoljniji uticaj na tok i 
ishod oboljenja. 
R a n a  d i j a g n o s t i k a  k a r c i n o m a  ž e l u c a  j e  o d  n a j v e će važnosti za povoljan ishod u 
preživljavanju ovih pacijenata. Veličina tumora (T), kao i patohistološki nalaz (PH), 
limfonodalni status (N) značajno utiču na radikalnost operativnog lečenja i udaljene 
metastaze. Primenom radikalne limfadenektomije sa totalnom i subtotalnom gastrekto-
mijom povećava se dužina preživljavanja, što očekujemo kod naših bolesnika koje i dalje 
pratimo a oni su u dobrom opštem stanju bez znakova recidiva. Primenom radikalne 
ekstenzivne limfadenektomije povećava se stopa preživljavanja. Acta Medica Medianae 
2008;47(3):44-50. 
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